Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Boston Scientific has signed a definitive agreement for the acquisition of an Ajax Health company, Cortex, to bolster its ...

Boston Scientific will purchase Ajax Health's Cortex and its OptiMap system to guide physicians performing AFib-treating ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

Continue Reading Boston Scientific has received U.S. FDA ... for cardiac ablation procedures with the FARAPULSETM Pulsed Field Ablation (PFA) System. Today, physicians may utilize a separate ...

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation ... Feast and Field ...

Oct. 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE ... for cardiac ablation procedures with the FARAPULSE™ Pulsed Field Ablation (PFA) System. These technologies are compatible ...